Cracking The Code: Understanding Analyst Reviews For Healthcare Realty Trust
Portfolio Pulse from Benzinga Insights
Healthcare Realty Trust (NYSE:HR) has been analyzed by 5 analysts, showing a shift towards a more cautious stance with 4 indifferent ratings recently. The average 12-month price target is now $15.6, marking a 13.33% decrease from previous targets. Financial indicators reveal challenges for HR, including a -2.25% revenue decline, below-average net margin, and ROE, but a healthier debt-to-equity ratio compared to peers. The company focuses on owning, leasing, and managing healthcare properties, with M&A as part of its growth strategy.
May 08, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Healthcare Realty Trust's analyst ratings have become more cautious, with a lowered average price target of $15.6. Financial challenges include a revenue decline and below-average profitability metrics, though a solid debt-to-equity ratio offers some positive outlook.
The cautious stance from analysts, combined with the company's financial challenges such as revenue decline and low profitability metrics, likely contribute to a negative short-term impact on HR's stock price. However, the company's strategic focus on healthcare real estate and a healthier debt-to-equity ratio provide some mitigating factors.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100